دانلود کتاب رویکردهای مبتنی بر نانوپزشکی برای درمان زوال عقل

Nanotechnology is progressively gaining interest of scientific fraternity mainly in biological applications for healthcare. However, still there are niche areas, where nanotechnology has limited applicability. The role of nanocarriers in the delivery of drugs has proven to be meritorious than the conventional ways of drug delivery. Particularly in diseases like cancer, diabetes, etc. nanocarriers have resulted into excellent outcome. However, brain disorders like Alzheimer’s, Parkinsonism, etc. pose an entirely different challenge as per as drug delivery is concerned. The access of drugs and other bioactives to brain is still a major challenge to deal with. Dementia is a syndrome in which cognitive behavior of a person deteriorates which is difficult to predict beyond aging. This can affect the daily tasks performed by that person including language, learning capacity, memory, comprehension, and ability to carry out simple tasks including judg­ment. More than 45 million people are affected by dementia worldwide. This chronic disease is reported in almost 10 million new cases every year and hence needs solid treatment strategies. Dementia is the result of several brain disorders which directly or indirectly affects the brain function such as Alzheimer’s, brain stroke, etc.